BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16518393)

  • 1. Early hematopoietic lineage restrictions directed by Ikaros.
    Yoshida T; Ng SY; Zuniga-Pflucker JC; Georgopoulos K
    Nat Immunol; 2006 Apr; 7(4):382-91. PubMed ID: 16518393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells.
    Ng SY; Yoshida T; Zhang J; Georgopoulos K
    Immunity; 2009 Apr; 30(4):493-507. PubMed ID: 19345118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ikaros isoform x is selectively expressed in myeloid differentiation.
    Payne KJ; Huang G; Sahakian E; Zhu JY; Barteneva NS; Barsky LW; Payne MA; Crooks GM
    J Immunol; 2003 Mar; 170(6):3091-8. PubMed ID: 12626565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoiesis flies high with Ikaros.
    Smale ST; Dorshkind K
    Nat Immunol; 2006 Apr; 7(4):367-9. PubMed ID: 16550201
    [No Abstract]   [Full Text] [Related]  

  • 5. Awakening lineage potential by Ikaros-mediated transcriptional priming.
    Yoshida T; Ng SY; Georgopoulos K
    Curr Opin Immunol; 2010 Apr; 22(2):154-60. PubMed ID: 20299195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular cell adhesion molecule-1 expression by hematopoiesis-supporting stromal cells is not essential for lymphoid or myeloid differentiation in vivo or in vitro.
    Friedrich C; Cybulsky MI; Gutierrez-Ramos JC
    Eur J Immunol; 1996 Nov; 26(11):2773-80. PubMed ID: 8921968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F4 modulates differentiation and gene expression in hematopoietic progenitor cells during commitment to the lymphoid lineage.
    Enos ME; Bancos SA; Bushnell T; Crispe IN
    J Immunol; 2008 Mar; 180(6):3699-707. PubMed ID: 18322175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors.
    Kelley CM; Ikeda T; Koipally J; Avitahl N; Wu L; Georgopoulos K; Morgan BA
    Curr Biol; 1998 Apr; 8(9):508-15. PubMed ID: 9560339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ikaros and chromatin regulation in early hematopoiesis.
    Ng SY; Yoshida T; Georgopoulos K
    Curr Opin Immunol; 2007 Apr; 19(2):116-22. PubMed ID: 17307348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene coexpression analysis in single cells indicates lymphomyeloid copriming in short-term hematopoietic stem cells and multipotent progenitors.
    Gautreau L; Boudil A; Pasqualetto V; Skhiri L; Grandin L; Monteiro M; Jais JP; Ezine S
    J Immunol; 2010 May; 184(9):4907-17. PubMed ID: 20368277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reporter mouse reveals lineage-specific and heterogeneous expression of IRF8 during lymphoid and myeloid cell differentiation.
    Wang H; Yan M; Sun J; Jain S; Yoshimi R; Abolfath SM; Ozato K; Coleman WG; Ng AP; Metcalf D; DiRago L; Nutt SL; Morse HC
    J Immunol; 2014 Aug; 193(4):1766-77. PubMed ID: 25024380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors.
    Scott EW; Fisher RC; Olson MC; Kehrli EW; Simon MC; Singh H
    Immunity; 1997 Apr; 6(4):437-47. PubMed ID: 9133423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ikaros gene is required for the development of all lymphoid lineages.
    Georgopoulos K; Bigby M; Wang JH; Molnar A; Wu P; Winandy S; Sharpe A
    Cell; 1994 Oct; 79(1):143-56. PubMed ID: 7923373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-InsR signaling drives multipotent progenitor differentiation toward lymphoid lineages.
    Xia P; Wang S; Du Y; Huang G; Satoh T; Akira S; Fan Z
    J Exp Med; 2015 Dec; 212(13):2305-21. PubMed ID: 26573296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes.
    Klug CA; Morrison SJ; Masek M; Hahm K; Smale ST; Weissman IL
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):657-62. PubMed ID: 9435248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune activation modulates hematopoiesis through interactions between CD27 and CD70.
    Nolte MA; Arens R; van Os R; van Oosterwijk M; Hooibrink B; van Lier RA; van Oers MH
    Nat Immunol; 2005 Apr; 6(4):412-8. PubMed ID: 15723067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene regulatory networks directing myeloid and lymphoid cell fates within the immune system.
    Laslo P; Pongubala JM; Lancki DW; Singh H
    Semin Immunol; 2008 Aug; 20(4):228-35. PubMed ID: 18771937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple hematopoietic defects and delayed globin switching in Ikaros null mice.
    Lopez RA; Schoetz S; DeAngelis K; O'Neill D; Bank A
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):602-7. PubMed ID: 11805317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate.
    De Luca K; Frances-Duvert V; Asensio MJ; Ihsani R; Debien E; Taillardet M; Verhoeyen E; Bella C; Lantheaume S; Genestier L; Defrance T
    Leukemia; 2009 Nov; 23(11):2063-74. PubMed ID: 19641520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bmi1 is critical to prevent Ikaros-mediated lymphoid priming in hematopoietic stem cells.
    Arranz L; Herrera-Merchan A; Ligos JM; de Molina A; Dominguez O; Gonzalez S
    Cell Cycle; 2012 Jan; 11(1):65-78. PubMed ID: 22185780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.